Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 3,500 | 1,414 | 3,000 | 10,000 | 0 |
| Cost of Goods | 1,605 | 450 | N/A | N/A | N/A |
| Gross Profit | 1,895 | 964 | 3,000 | 10,000 | N/A |
| Operating Expenses | 49,635 | 52,329 | 92,836 | 91,420 | 77,090 |
| Operating Income | -47,135 | -50,915 | -89,836 | -81,420 | -77,090 |
| Interest Expense | 418 | 736 | 3,656 | 4,115 | 400 |
| Other Income | -6,635 | 11,955 | 8,556 | 1,301 | 1,208 |
| Pre-tax Income | -54,188 | -39,696 | -84,936 | -84,234 | -76,282 |
| Net Income Continuous | -54,188 | -39,696 | -84,936 | -84,234 | -76,282 |
| Net Income | $-54,188 | $-39,696 | $-84,936 | $-84,234 | $-76,282 |
| EPS Basic Total Ops | -2.53 | -5.53 | -21.57 | -22.75 | -37.75 |
| EPS Basic Continuous Ops | -2.53 | -5.05 | -21.57 | -22.73 | -37.87 |
| EPS Diluted Total Ops | -2.53 | -5.53 | -21.57 | -22.75 | -37.75 |
| EPS Diluted Continuous Ops | -2.53 | -5.05 | -21.57 | -22.73 | -37.87 |
| EPS Diluted Before Non-Recurring Items | -2.05 | -4.81 | -15.50 | -13.75 | -37.75 |
| EBITDA(a) | $-43,937 | $-46,338 | $-85,372 | $-75,819 | $-69,271 |